Company Filing History:
Years Active: 1995-1999
Title: Franco C Lori: Innovator in HIV-1 Research
Introduction
Franco C Lori is a prominent inventor based in Bethesda, MD (US). He has made significant contributions to the field of HIV research, holding a total of 3 patents. His work focuses on the molecular cloning of HIV-1 viral strains, which has important implications for vaccine development and diagnostic testing.
Latest Patents
Franco C Lori's latest patents include the following:
1. **Molecular clones of HIV-1 viral strains MN-ST1 and BA-L, and uses thereof** - This invention relates to the HIV-1 strains MN-ST1 and BA-L, which are typical United States HIV-1 isotypes. It involves DNA segments encoding the envelope protein of MN-ST1 or BA-L, DNA constructs containing such segments, and host cells transformed with these constructs. The viral isolates and envelope proteins are valuable for use in vaccines and bioassays for detecting HIV-1 infection in biological samples, such as blood bank samples.
2. **Molecular clones of HIV-1 viral strains MH-ST1 and BA-L, and uses thereof** - Similar to the previous patent, this invention also focuses on the HIV-1 strains MN-ST1 and BA-L. It includes DNA segments encoding the envelope protein, DNA constructs, and transformed host cells. The applications of these viral isolates and proteins are crucial for vaccine development and HIV-1 detection in biological samples.
Career Highlights
Franco C Lori works for the United States of America as represented by the Department of Health. His research has been instrumental in advancing the understanding of HIV-1 and developing potential therapeutic solutions.
Collaborations
Franco has collaborated with notable colleagues, including Marvin S Reitz, Jr and Genoveffa Franchini. Their combined expertise has contributed to the success of their research endeavors.
Conclusion
Franco C Lori is a dedicated inventor whose work in HIV-1 research has led to significant advancements in the field. His patents reflect his commitment to improving public health through innovative solutions.